Presentation Open Access

HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level

Harding, Rachel


Citation Style Language JSON Export

{
  "publisher": "Zenodo", 
  "DOI": "10.5281/zenodo.3383392", 
  "title": "HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level", 
  "issued": {
    "date-parts": [
      [
        2019, 
        6, 
        28
      ]
    ]
  }, 
  "abstract": "<p>Presentation at&nbsp;HDSA Convention 2019 in Boston in &quot;Moving Beyond Mice: Understanding HD in People&quot; session.</p>", 
  "author": [
    {
      "family": "Harding, Rachel"
    }
  ], 
  "note": "Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, S\u00e3o Paulo Research Foundation-FAPESP, Takeda, and Wellcome.", 
  "type": "speech", 
  "id": "3383392"
}
85
161
views
downloads
All versions This version
Views 8585
Downloads 161161
Data volume 4.7 GB4.7 GB
Unique views 7878
Unique downloads 156156

Share

Cite as